Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 351

1.

Antimicrobial and immunoregulatory properties of human tryptophan 2,3-dioxygenase.

Schmidt SK, Müller A, Heseler K, Woite C, Spekker K, MacKenzie CR, Däubener W.

Eur J Immunol. 2009 Oct;39(10):2755-64. doi: 10.1002/eji.200939535.

2.

Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).

Sarkhosh K, Tredget EE, Karami A, Uludag H, Iwashina T, Kilani RT, Ghahary A.

J Cell Biochem. 2003 Sep 1;90(1):206-17.

PMID:
12938169
3.

Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Meisel R, Zibert A, Laryea M, Göbel U, Däubener W, Dilloo D.

Blood. 2004 Jun 15;103(12):4619-21. Epub 2004 Mar 4.

4.

Regulation of IDO activity by oxygen supply: inhibitory effects on antimicrobial and immunoregulatory functions.

Schmidt SK, Ebel S, Keil E, Woite C, Ernst JF, Benzin AE, Rupp J, Däubener W.

PLoS One. 2013 May 13;8(5):e63301. doi: 10.1371/journal.pone.0063301. Print 2013.

5.

Temperature-sensitive polymer-conjugated IFN-gamma induces the expression of IDO mRNA and activity by fibroblasts populated in collagen gel (FPCG).

Sarkhosh K, Tredget EE, Uludag H, Kilani RT, Karami A, Li Y, Iwashina T, Ghahary A.

J Cell Physiol. 2004 Oct;201(1):146-54.

PMID:
15281097
6.

Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase.

Habara-Ohkubo A, Shirahata T, Takikawa O, Yoshida R.

Infect Immun. 1993 May;61(5):1810-3.

7.

Selective inhibition of IDO1 effectively regulates mediators of antitumor immunity.

Liu X, Shin N, Koblish HK, Yang G, Wang Q, Wang K, Leffet L, Hansbury MJ, Thomas B, Rupar M, Waeltz P, Bowman KJ, Polam P, Sparks RB, Yue EW, Li Y, Wynn R, Fridman JS, Burn TC, Combs AP, Newton RC, Scherle PA.

Blood. 2010 Apr 29;115(17):3520-30. doi: 10.1182/blood-2009-09-246124. Epub 2010 Mar 2.

8.

Human indoleamine 2,3-dioxygenase inhibits Toxoplasma gondii growth in fibroblast cells.

Dai W, Pan H, Kwok O, Dubey JP.

J Interferon Res. 1994 Dec;14(6):313-7.

PMID:
7897249
9.
10.

The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects.

Müller A, Heseler K, Schmidt SK, Spekker K, Mackenzie CR, Däubener W.

J Cell Mol Med. 2009 Jun;13(6):1125-35. doi: 10.1111/j.1582-4934.2008.00542.x. Epub 2009 Oct 13.

11.

Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.

Boasso A, Herbeuval JP, Hardy AW, Winkler C, Shearer GM.

Blood. 2005 Feb 15;105(4):1574-81. Epub 2004 Oct 5.

12.

Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase.

Funeshima N, Fujino M, Kitazawa Y, Hara Y, Hara Y, Hayakawa K, Okuyama T, Kimura H, Li XK.

J Gene Med. 2005 May;7(5):565-75.

PMID:
15543532
13.

Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism.

Taylor MW, Feng GS.

FASEB J. 1991 Aug;5(11):2516-22. Review.

PMID:
1907934
14.

Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta.

Kudo Y, Boyd CA, Spyropoulou I, Redman CW, Takikawa O, Katsuki T, Hara T, Ohama K, Sargent IL.

J Reprod Immunol. 2004 Apr;61(2):87-98.

PMID:
15063632
15.

High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death.

Habibi D, Jalili RB, Forouzandeh F, Ong CJ, Ghahary A.

J Cell Physiol. 2010 Oct;225(1):196-205. doi: 10.1002/jcp.22220.

PMID:
20648630
16.

Antimicrobial and immunoregulatory effects mediated by human lung cells: role of IFN-gamma-induced tryptophan degradation.

Heseler K, Spekker K, Schmidt SK, MacKenzie CR, Däubener W.

FEMS Immunol Med Microbiol. 2008 Mar;52(2):273-81. doi: 10.1111/j.1574-695X.2007.00374.x. Epub 2008 Jan 16.

17.

Role of indoleamine 2,3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines.

MacKenzie CR, Heseler K, Müller A, Däubener W.

Curr Drug Metab. 2007 Apr;8(3):237-44. Review.

PMID:
17430112
19.

Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.

Mellor AL, Chandler P, Baban B, Hansen AM, Marshall B, Pihkala J, Waldmann H, Cobbold S, Adams E, Munn DH.

Int Immunol. 2004 Oct;16(10):1391-401. Epub 2004 Sep 6.

PMID:
15351783
20.

Inducible anti-parasitic effector mechanisms in human uroepithelial cells: tryptophan degradation vs. NO production.

Däubener W, Posdziech V, Hadding U, MacKenzie CR.

Med Microbiol Immunol. 1999 Mar;187(3):143-7.

PMID:
10206145

Supplemental Content

Support Center